S&P 500   4,297.14
DOW   33,912.44
QQQ   333.06
The Five Hottest Calls From The Q2 Earnings Season 
New $2.2 Quadrillion Trend About To Open Up (Ad)pixel
Buffett's firm buys more Apple, Amazon while betting on oil
Norway hits export record amid soaring gas prices
Stocks end higher on Wall Street; economic worries hit oil
The 32-Second Options Trading "Training Video" Retirees Can't Get Enough Of (Ad)
Myanmar executions revive pressure for more sanctions
Stocks higher on Wall Street; economic worries hit oil price
New climate deal spurs hopes of more carbon storage projects
"Prepare for Five Years of Famine" (Ad)
S&P 500   4,297.14
DOW   33,912.44
QQQ   333.06
The Five Hottest Calls From The Q2 Earnings Season 
New $2.2 Quadrillion Trend About To Open Up (Ad)pixel
Buffett's firm buys more Apple, Amazon while betting on oil
Norway hits export record amid soaring gas prices
Stocks end higher on Wall Street; economic worries hit oil
The 32-Second Options Trading "Training Video" Retirees Can't Get Enough Of (Ad)
Myanmar executions revive pressure for more sanctions
Stocks higher on Wall Street; economic worries hit oil price
New climate deal spurs hopes of more carbon storage projects
"Prepare for Five Years of Famine" (Ad)
S&P 500   4,297.14
DOW   33,912.44
QQQ   333.06
The Five Hottest Calls From The Q2 Earnings Season 
New $2.2 Quadrillion Trend About To Open Up (Ad)pixel
Buffett's firm buys more Apple, Amazon while betting on oil
Norway hits export record amid soaring gas prices
Stocks end higher on Wall Street; economic worries hit oil
The 32-Second Options Trading "Training Video" Retirees Can't Get Enough Of (Ad)
Myanmar executions revive pressure for more sanctions
Stocks higher on Wall Street; economic worries hit oil price
New climate deal spurs hopes of more carbon storage projects
"Prepare for Five Years of Famine" (Ad)
S&P 500   4,297.14
DOW   33,912.44
QQQ   333.06
The Five Hottest Calls From The Q2 Earnings Season 
New $2.2 Quadrillion Trend About To Open Up (Ad)pixel
Buffett's firm buys more Apple, Amazon while betting on oil
Norway hits export record amid soaring gas prices
Stocks end higher on Wall Street; economic worries hit oil
The 32-Second Options Trading "Training Video" Retirees Can't Get Enough Of (Ad)
Myanmar executions revive pressure for more sanctions
Stocks higher on Wall Street; economic worries hit oil price
New climate deal spurs hopes of more carbon storage projects
"Prepare for Five Years of Famine" (Ad)
NASDAQ:AERI

Aerie Pharmaceuticals - AERI News Headlines

$11.74
+0.17 (+1.47%)
(As of 08/15/2022 12:00 AM ET)
Add
Compare
Today's Range
$11.00
$11.80
50-Day Range
$5.68
$11.64
52-Week Range
$4.81
$17.21
Volume
574,850 shs
Average Volume
750,054 shs
Market Capitalization
$579.49 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$20.50
Get Aerie Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for AERI and its competitors with MarketBeat's FREE daily newsletter.

AERI Media Mentions By Week

AERI Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

AERI
News Sentiment

1.13

0.63

Average
Medical
News Sentiment

AERI News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

AERI Articles
This Week

14

2

AERI Articles
Average Week



SourceHeadline
marketbeat.com logoAerie Pharmaceuticals (NASDAQ:AERI) PT Raised to $14.00 at Citigroup
marketbeat.com - August 15 at 11:31 PM
marketbeat.com logoCitigroup Increases Aerie Pharmaceuticals (NASDAQ:AERI) Price Target to $14.00
marketbeat.com - August 9 at 1:48 PM
marketbeat.com logoAerie Pharmaceuticals (NASDAQ:AERI) Sees Large Volume Increase on Analyst Upgrade
marketbeat.com - August 9 at 1:40 PM
finance.yahoo.com logoWall Street Analysts See a 75% Upside in Aerie (AERI): Can the Stock Really Move This High?
finance.yahoo.com - August 11 at 6:31 PM
MarketBeat logoAerie Pharmaceuticals (NASDAQ:AERI) Sees Large Volume Increase After Analyst Upgrade
americanbankingnews.com - August 11 at 1:52 AM
MarketBeat logoAerie Pharmaceuticals (NASDAQ:AERI) Price Target Raised to $14.00 at Citigroup
americanbankingnews.com - August 10 at 6:44 AM
finance.yahoo.com logoDurham pharma looks to turn the corner following C-suite shakeup
finance.yahoo.com - August 9 at 8:10 AM
seekingalpha.com logoAerie Pharmaceuticals, Inc.'s (AERI) CEO Raj Kannan on Q2 2022 Results - Earnings Call Transcript
seekingalpha.com - August 7 at 1:10 PM
seekingalpha.com logoAerie Pharmaceuticals Q2 2022 Earnings Preview
seekingalpha.com - August 5 at 8:33 PM
finance.yahoo.com logoAerie (AERI) Q2 Loss Narrower Than Expected, Sales Beat
finance.yahoo.com - August 5 at 3:33 PM
finance.yahoo.com logoAerie Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update
finance.yahoo.com - August 4 at 7:28 PM
markets.businessinsider.com logoAerie Shares Gain Following Patient Dosing In Late-Stage Dry Eye Disease Study
markets.businessinsider.com - August 1 at 7:11 PM
finance.yahoo.com logoAerie Pharmaceuticals Announces First Participant Dosed in the COMET-3 Study of AR-15512 for the Treatment of Dry Eye Disease
finance.yahoo.com - August 1 at 7:10 PM
finance.yahoo.com logoAerie Pharmaceuticals to Announce Second Quarter 2022 Financial Results and Host Conference Call on Thursday, August 4, 2022 at 5:00 p.m. ET
finance.yahoo.com - July 28 at 6:37 PM
finance.yahoo.com logoAerie Pharmaceuticals Announces New Employee Inducement Grant
finance.yahoo.com - July 8 at 8:54 AM
finance.yahoo.com logoAerie Pharmaceuticals to Participate in the Jefferies Healthcare Conference on Friday, June 10, 2022 at 10:30 a.m. ET
finance.yahoo.com - May 25 at 6:30 PM
markets.businessinsider.com logoAerie Pharmaceuticals Begins Patient Dosing In Late-Stage Dry Eye Disease Study
markets.businessinsider.com - May 24 at 9:22 PM
seekingalpha.com logoAerie Pharmaceuticals begins dosing in late-stage study of AR-15512 for dry eye disease
seekingalpha.com - May 24 at 4:20 PM
finance.yahoo.com logoAerie Pharmaceuticals Announces First Participant Dosed in the Phase 3 Registrational COMET-2 Study of AR-15512 for the Treatment of Dry Eye Disease
finance.yahoo.com - May 24 at 11:01 AM
markets.businessinsider.com logoHC Wainwright & Co. Maintains Buy Rating for Aerie Pharmaceuticals: Here's What You Need To Know
markets.businessinsider.com - May 9 at 3:50 PM
seekingalpha.com logoAerie Pharmaceuticals' (AERI) CEO Raj Kannan on Q1 2022 Results - Earnings Call Transcript
seekingalpha.com - May 7 at 10:23 AM
finance.yahoo.com logoFurther weakness as Aerie Pharmaceuticals (NASDAQ:AERI) drops 12% this week, taking three-year losses to 85%
finance.yahoo.com - May 7 at 10:23 AM
finance.yahoo.com logoAerie (AERI) Q1 Loss Wider Than Expected, Revenues Rise Y/Y
finance.yahoo.com - May 6 at 6:16 PM
finance.yahoo.com logoAerie Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Update
finance.yahoo.com - May 5 at 5:12 PM
seekingalpha.com logoAerie Pharmaceuticals Q1 consensus EPS, revenue estimates up
seekingalpha.com - May 4 at 5:54 PM
finance.yahoo.com logoAerie Pharmaceuticals to Announce First Quarter 2022 Financial Results and Host Conference Call on Thursday, May 5, 2022 at 5:00 p.m. ET
finance.yahoo.com - April 28 at 9:00 PM
finance.yahoo.com logoAerie Pharmaceuticals Announces Presentations at the Association for Research in Vision and Ophthalmology Annual Meeting in Denver, Colorado, May 1-4, 2022
finance.yahoo.com - April 26 at 5:16 PM
finance.yahoo.com logoAerie Pharmaceuticals Announces Presentations at the American Society of Cataract and Refractive Surgery (ASCRS 2022) in Washington, D.C., April 22-26, 2022
finance.yahoo.com - April 20 at 6:34 PM
finance.yahoo.com logoAerie Pharmaceuticals to Participate in the 21st Annual Needham Virtual Healthcare Conference on Tuesday, April 12, 2022 at 3:00 p.m. ET
finance.yahoo.com - April 6 at 7:22 PM
fool.com logoAerie Pharmaceuticals (AERI)
fool.com - March 18 at 10:03 AM
markets.businessinsider.com logoAerie Gets New CFO
markets.businessinsider.com - March 18 at 10:03 AM
marketwatch.com logoAerie Pharmaceuticals Names Peter Lang CFO
marketwatch.com - March 18 at 10:03 AM
seekingalpha.com logoAerie Pharmaceuticals appoints new finance chief
seekingalpha.com - March 18 at 10:03 AM
finance.yahoo.com logoAerie Pharmaceuticals Appoints Peter Lang as Chief Financial Officer
finance.yahoo.com - March 18 at 10:03 AM
seekingalpha.com logoAerie, Schrodinger top healthcare gainers; while Baudax Bio, The Joint lead losers' pack
seekingalpha.com - February 25 at 12:48 PM
seekingalpha.com logoAerie swings to profits in Q4 thanks to licensing deal with Santen
seekingalpha.com - February 25 at 12:48 PM
finance.yahoo.com logoAerie (AERI) Q4 Earnings Beat Estimates, Revenues Up Y/Y
finance.yahoo.com - February 25 at 12:48 PM
benzinga.com logoAerie Pharmaceuticals Q4 EPS $1.09 Up From $(0.79) YoY, Sales $114.67M Up From $24.68M YoY
benzinga.com - February 24 at 8:52 PM
apnews.com logoAerie: Q4 Earnings Snapshot
apnews.com - February 24 at 8:52 PM
benzinga.com logoRecap: Aerie Pharmaceuticals Q4 Earnings
benzinga.com - February 24 at 8:52 PM
finance.yahoo.com logoAerie Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
finance.yahoo.com - February 24 at 8:52 PM
finance.yahoo.com logoAerie Pharmaceuticals (AERI) Tops Q4 Earnings and Revenue Estimates
finance.yahoo.com - February 24 at 8:52 PM
seekingalpha.com logoAerie Pharmaceuticals Q4 2021 Earnings Preview
seekingalpha.com - February 24 at 10:51 AM
seekingalpha.com logoAerie Pharmaceuticals appoints Gary Sternberg as medical chief
seekingalpha.com - February 24 at 10:51 AM
finance.yahoo.com logoAerie Pharmaceuticals Appoints Gary Sternberg, M.D., M.B.A. as Chief Medical Officer
finance.yahoo.com - February 24 at 10:51 AM
benzinga.com logoAerie Pharmaceuticals to Announce Fourth Quarter...
benzinga.com - February 17 at 7:08 PM
finance.yahoo.com logoAerie Pharmaceuticals (AERI) May Report Negative Earnings: Know the Trend Ahead of Q4 Release
finance.yahoo.com - February 17 at 7:08 PM
finance.yahoo.com logoAerie Pharmaceuticals to Announce Fourth Quarter and Full Year 2021 Financial Results and Host Conference Call on Thursday, February 24, 2022 at 5:00 p.m. ET
finance.yahoo.com - February 17 at 7:08 PM
finance.yahoo.com logoMarket Sentiment Around Loss-Making Aerie Pharmaceuticals, Inc. (NASDAQ:AERI)
finance.yahoo.com - February 3 at 11:05 AM
bizjournals.com logoExecutive shakeup continues at Durham pharma in wake of CEO change
bizjournals.com - January 26 at 6:01 PM
finance.yahoo.com logoAerie Pharmaceuticals Reports Inducement Grant to Chief Executive Officer Under Nasdaq Listing Rule 5635(c)(4)
finance.yahoo.com - December 22 at 5:35 PM
finance.yahoo.com logoTBJ Plus: New CEO takes helm at Durham pharma; $1.5B deal has Triangle link; Big name change in Wilmington
finance.yahoo.com - December 22 at 12:35 PM
finance.yahoo.com logoAerie Pharmaceuticals Appoints Raj Kannan as Chief Executive Officer
finance.yahoo.com - December 16 at 9:58 AM
Get Aerie Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for AERI and its competitors with MarketBeat's FREE daily newsletter.

This page (NASDAQ:AERI) was last updated on 8/16/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.